Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

Kefeli, UmutArslan, CagatayYildirim, Mahmut EmreIsikdogan, AbdurrahmanKaradurmus, NuriKarabulut, BulentCubukcu, ErdemCicin, IrfanYalcin, SuayibTurk, Haci M.Bilir, CemilKaraca, MustafaArtac, MehmetSendur, Mehmet NahitAlacacioglu, AhmetSimsek, Eda TanrikuluDane, FaysalBilici, AhmetCevik, DuyguGumus, Mahmut2021-11-302021-11-302021-05-01Kefeli U., Arslan C., Yildirim M. E. , Isikdogan A., Karadurmus N., Karabulut B., Cubukcu E., Cicin I., Yalcin S., Turk H. M. , et al., -Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.-, JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021http://hdl.handle.net/20.500.12645/29678Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.ArticleWOS:00070812030122610.1200/jco.2021.39.15_suppl.e15561